Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen casesYOSHIDA, Yataro; OGUMA, Shigeru; OHNO, Hitoshi et al.International journal of hematology. 2014, Vol 99, Num 6, pp 721-725, issn 0925-5710, 5 p.Article

A case of myelodysplastic syndrome presenting with faggot-like cellsOGURA, Hiroka; INAGAKI, Atsushi; WAKITA, Atsushi et al.International journal of hematology. 2013, Vol 97, Num 4, pp 443-445, issn 0925-5710, 3 p.Article

Treatment of myelodysplastic syndrome with cyclosporin ASHUCHANG CHEN; BIN JIANG; WANMING DA et al.International journal of hematology. 2007, Vol 85, Num 1, pp 11-17, issn 0925-5710, 7 p.Article

Mutations in epigenetic regulators in myelodysplastic syndromesNIKOLOSKI, Gorica; DER REIJDEN, Bert A. Van; JANSEN, Joop H et al.International journal of hematology. 2012, Vol 95, Num 1, pp 8-16, issn 0925-5710, 9 p.Article

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromesBOWEN, David; CULLICAN, Dominic; JOWITT, Simon et al.British journal of haematology. 2003, Vol 120, Num 2, pp 187-200, issn 0007-1048, 14 p.Article

Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesDAVIDOFF, Amy J; SMITH, Sheila Weiss; BAER, Maria R et al.Haematologica (Roma). 2012, Vol 97, Num 1, pp 128-132, issn 0390-6078, 5 p.Article

The Impact of Cytomorphology, Cytogenetics, Molecular Genetics, and Immunophenotyping in a Comprehensive Diagnostic Workup of Myelodysplastic SyndromesBACHER, Ulrike; HAFERLACH, Torsten; KERN, Wolfgang et al.Cancer. 2009, Vol 115, Num 19, pp 4524-4532, issn 0008-543X, 9 p.Article

Recurrent DNMT3A mutations in patients with myelodysplastic syndromesWALTER, M. J; DING, L; KANDOTH, C et al.Leukemia. 2011, Vol 25, Num 7, pp 1153-1158, issn 0887-6924, 6 p.Article

The evolution of hematopoietic SCT in myelodysplastic syndromeKINDWALL-KELLER, T; ISOLA, L. M.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 8, pp 597-609, issn 0268-3369, 13 p.Article

A prognostic score for patients with lower risk myelodysplastic syndromeGARCIA-MANERO, G; SHAN, J; HUANG, X et al.Leukemia. 2008, Vol 22, Num 3, pp 538-543, issn 0887-6924, 6 p.Article

CD34⁺ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndromeHEINRICHS, Stefan; BERMAN, Jason N; ORTIZ, Taylor M et al.British journal of haematology. 2005, Vol 130, Num 1, pp 83-86, issn 0007-1048, 4 p.Article

Pathological splenic rupture : A rare complication of chronic myelomonocytic leukemiaGODDARD, Shannon Lynn; CHESNEY, Alden E; REIS, Marciano D et al.American journal of hematology. 2007, Vol 82, Num 5, pp 405-408, issn 0361-8609, 4 p.Article

Infections in myelodysplastic syndromesTOMA, Andrea; FENAUX, Pierre; DREYFUS, François et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1459-1470, issn 0390-6078, 12 p.Article

Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemiaKEITH, Tamara; ARAKI, Yuko; OHYAGI, Masaki et al.British journal of haematology. 2007, Vol 137, Num 3, pp 206-215, issn 0007-1048, 10 p.Article

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromesBOWEN, David; GERMING, Ulrich; HAAS, Rainer et al.Haematologica (Roma). 2006, Vol 91, Num 12, issn 0390-6078, 1583-15883,1596-1604 [10 p.]Article

Les syndromes myélodysplasiques = Myelodysplastic syndromesBEYNE-RAUZY, O.La Revue de médecine interne (Paris). 2012, Vol 33, issn 0248-8663, A21-A23, HSConference Paper

Les syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2006, Vol 12, pp 39-42, issn 1264-7527, 4 p., NS2Conference Paper

Syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2005, Vol 11, pp 43-45, issn 1264-7527, 3 p., NS4Conference Paper

Fifth international symposium on myelodysplastic syndromes, Prague, Czech Republic, 21-24 April 1999NEUWIRTOVA, Radana; CMUNT, Eduard; JELINEK, Jaroslav et al.Leukemia research. 1999, Vol 23, issn 0145-2126, 92 p., SUP1Conference Proceedings

Biology and pathogenesis of the myelodysplastic syndromesLIST, A. F; JACOBS, A.Seminars in oncology. 1992, Vol 19, Num 1, pp 14-24, issn 0093-7754Article

Actualités dans les syndromes myélodysplasiquesFENAUX, P.La Revue de médecine interne (Paris). 2014, Vol 35, Num JUN, issn 0248-8663, A16-A17, HSConference Paper

Syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2007, Vol 13, pp 45-49, issn 1264-7527, 5 p., NS1Conference Paper

Les syndromes myélodysplasiques ou états préleucémiques = Myelodysplastic syndromeGARDIN, Claude; FENAUX, Pierre.Concours médical (Paris). 2004, Vol 126, Num 27, pp 1577-1581, issn 0010-5309, 5 p.Article

Les syndromes myélodysplasiques (1ère partie) = Myelodysplastic syndromes (1st part)FENAUX, P.Pathologie et biologie. 1997, Vol 45, Num 7, issn 0369-8114, 79 p.Serial Issue

Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-CFENAUX, Pierre; GATTERMANN, Norbert; MCKENZIE, David et al.British journal of haematology. 2010, Vol 149, Num 2, pp 244-249, issn 0007-1048, 6 p.Article